Login to Your Account



Zai's series B brings $100M-plus for R&D in China, global markets

By Shannon Ellis
Staff Writer

Friday, January 8, 2016

SHANGHAI – Zai Labs Ltd., of Shanghai, has done it again, this time raising more than $100 million from seasoned health care venture firms led by Advantech Capital and Orbimed.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription